Study Objective: The primary objective of this study was to describe vaginal hysterectomy practice patterns as well as facilitators and inhibitors to performing vaginal hysterectomy among gynecologic surgeons. Secondary objectives were to describe facilitators and inhibitors to the teaching and training of vaginal hysterectomy.
Design: A quantitative analysis of an online survey and qualitative analyses of the one-on-one interviews with gynecologic surgeons were conducted. This study was approved by the institutional review board.
Setting: Online survey and one-on-one virtual interviews.
Patients: Members of the American Association of Gynecologic Laparoscopists and the Society of Gynecologic Surgeons.
Interventions: None.
Measurements And Main Results: A total of 505 gynecologic surgeons completed the survey. Most surgeons were white (66.9%) and had a clinic in North America (67.5%). Approximately 48% of respondents reported "no barrier" to performing vaginal hysterectomies including pathology, visualization and exposure, and performance of concomitant procedures. Higher surgical volume was the only factor most commonly rated by surgeons as enabling the teaching of vaginal hysterectomy "quite a bit" (31.3%). Most surgeons agreed that vaginal hysterectomies are important to women's health (82.8%) and that all gynecologic surgeons should be able to perform vaginal hysterectomies (66.3%). In terms of medical education and training, most surgeons thought that residents should be required to achieve competency for vaginal hysterectomy before graduation (71.7%) and disagreed (56.0%) that we should eliminate residency graduation requirements for vaginal hysterectomy numbers. From the one-on-one interviews, major themes identified included advocacy, centralizing efforts, compensation and incentives, cycle of low experience, decreasing regional trends, lack of industry support, transvaginal vs laparoscopy culture, varied training targets and resources, innovations in training, and self-motivation.
Conclusions: Vaginal hysterectomy remains important to our field. Identified barriers and major themes from this study can direct future efforts to increase its adoption.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jmig.2024.12.002 | DOI Listing |
BMC Pregnancy Childbirth
January 2025
Department of Obstetrics and Gynaecology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, 151001, India.
Background: Placenta accreta spectrum (PAS) disorder is a fatal condition responsible for obstetric haemorrhage, which contributes to increased feto-maternal morbidity and mortality. The main contributing factor is a scarred uterus, often from a previous cesarean delivery, myomectomy, or uterine instrumentation. The occurrence of PAS in an unscarred uterus is extremely rare, with only anecdotal cases reported so far in the literature.
View Article and Find Full Text PDFJ Clin Med
December 2024
Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria.
: The objective of this study is to prospectively collect dosimetric and clinical data on vaginal cuff electronic brachytherapy and propose a protocol for the procedure. Twenty-five patients who had proven endometrial or cervical carcinoma and had undergone radical hysterectomy have been treated with vaginal cuff electronic brachytherapy. Treatment session durations and doses to the targets and the organs at risk have been extracted from the treatment planning software.
View Article and Find Full Text PDFDiagnostics (Basel)
December 2024
Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
Background/objectives: This systematic review aimed to evaluate the outcomes of minimally invasive techniques in gynecological cancer surgery, specifically laparoscopic hysterectomies (LHs), robotic-assisted hysterectomies (RHs), and laparoscopic-assisted vaginal hysterectomies (LAVHs).
Methods: We conducted a comprehensive search of electronic databases including PubMed and MedLine from January 2010 to August 2024. The search included randomized controlled trials (RCTs) and observational studies.
BMJ Case Rep
January 2025
Kansai Medical University, Hirakata Hospital, Hirakata, Japan.
SMARCA4-deficient undifferentiated cervical carcinoma is an extremely rare and aggressive malignancy, and effective treatment options are lacking. We experienced a rare case involving a patient with SMARCA4-deficient undifferentiated cervical carcinoma who was successfully managed in the long term. A woman in her 40s presented with a chief complaint of abnormal vaginal bleeding.
View Article and Find Full Text PDFUrogynecology (Phila)
October 2024
Atrium Wake Forest Baptist Health, Winston-Salem, NC.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!